Pneumococcal
Share our resources to support your local pneumococcal immunization awareness campaign!
Social Media Images
Pneumococcal disease – children under two years of age
(social media image for Twitter – .jpg: 303 KB)
Pneumococcal disease – children under two years of age
(social media image for Facebook – .jpg: 205 KB)
Pneumococcal disease – children under two years of age
(social media image for Instagram Story – .jpg: 414 KB)
Children under two years of age are among those at highest risk of pneumococcal infection.
(social media image for Twitter – .jpg: 261 KB)
Children under two years of age are among those at highest risk of pneumococcal infection.
(social media image for Instagram – .jpg: 253 KB)
Pneumococcal disease is a complication of influenza.
(social media image for Instagram – .jpg: 318 KB)
Pneumococcal disease – adults 65+ and adults living with a chronic illness
(social media image for Twitter – .jpg: 344 KB)
Pneumococcal disease – adults 65+ and adults living with a chronic illness
(social media image for Instagram – .jpg: 298 KB)
Pneumococcal disease – adults 65+ and adults living with a chronic illness
(social media image for Instagram Story – .jpg: 500 KB)
Pneumococcal disease is a complication of influenza.
(social media image for Facebook – .jpg: 211 KB)
Pneumococcal disease is a complication of influenza.
(social media image for Instagram – .jpg: 328 KB)
Adults 65 and older and adults with a chronic illness are among those at highest risk of pneumococcal infection.
(social media image for Facebook – .jpg: 232 KB)
Adults 65 and older and adults with a chronic illness are among those at highest risk of pneumococcal infection.
(social media image for Instagram – .jpg: 342 KB)
NACI Statements 2023
Recommendations on the use of conjugate pneumococcal vaccine – 15 valent (PNEU-C-15) and 20 valent (PNEU-C-20) in adults. Economic evidence supplementary appendix. National Advisory Committee on Immunization. 24 February 2023.
Summary of National Advisory Committee on Immunization (NACI) Statement of February 2023: Public Health Level Recommendations on the Use of Pneumococcal Vaccines in Adults, Including the Use of 15-Valent and 20-Valent Conjugate Vaccines. National Advisory Committee on Immunization. 24 February 2023.